查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067544

半固態製劑契約製造市場規模、佔有率和趨勢分析報告：按類型、產品類型、最終用途、公司規模、地區和細分市場預測（2026-2033 年）

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Type, By Product, By End Use, By Company Size, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

半固態製劑契約製造概述

2025 年全球半固態劑型契約製造市場規模預計為 212.1 億美元，預計到 2033 年將達到 503.6 億美元，2026 年至 2033 年的複合年成長率為 11.5%。

由於對皮膚科製劑的需求不斷成長、外包趨勢的轉變、對患者友好型藥物的需求不斷成長，以及皮膚病、關節炎和疼痛管理等慢性疾病的患病率不斷上升，市場正在成長。

此外，由於成本效益，對生產外包的需求不斷成長，預計將推動市場成長。技術進步，包括法規遵循、品質保證和製劑技術創新，預計也將在預測期內推動市場成長。此外，由於許多製藥公司專注於藥物發現和商業化等核心業務，契約製造組織 (CMO) 已成為半固態製劑開發、規模化生產和商業化生產中不可或缺的合作夥伴。

乳膏、軟膏、凝膠和洗劑等半固態製劑因其能夠進行局部標靶治療且患者用藥依從性高，正日益成為重要的製劑類別。這些製劑在皮膚科和疼痛管理領域尤其有利，因為直接塗抹於患處可加速起效、減少全身暴露並提高安全性。此外，從商業性角度來看，其非侵入性和易用性使其成為治療慢性疾病的理想選擇，進一步推動了市場成長。

此外，全球皮膚疾病負擔的日益加重預計也將推動市場成長。全球有超過18億人受到3000多種皮膚疾病的影響，皮膚疾病是全球疾病負擔的主要因素之一。此外，關節炎盛行率的上升（影響全球超過3.5億人）以及老年人口的成長，進一步推動了局部止痛藥和抗發炎藥物的使用。這些產品因其能夠降低口服藥物常見的胃腸道風險而備受青睞。

此外，技術創新有望推動市場發展，因為製劑科學的進步，例如奈米乳劑、脂質奈米顆粒遞送系統和滲透增強技術，已顯著提高了藥物的療效、穩定性和患者遵守用藥。契約製造組織 (CMO) 正在大力投資自動化生產系統、連續生產流程以及先進的混合和均質設備，以確保批次品質的一致性、符合法規要求並實現成本效益。此外，品質源自於設計 (QbD) 框架和數位化監控工具的引入正在改善製程控制並縮短產品上市時間。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：半固態製劑契約製造市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技
  • 定價模式分析
  • 關稅影響分析
  • 價值鏈分析
  • 市場分析工具

第4章：半固態製劑契約製造市場：按類型分類的估算與趨勢分析

  • 半固態製劑契約製造市場：基於類型的波動分析
  • 半固態製劑契約製造市場：按類型分類，估算和預測（2021-2033 年）
  • 外用
  • 經皮吸收
  • 口服

第5章：半固態製劑契約製造市場：產品特定估算與趨勢分析

  • 半固態製劑契約製造市場：基於產品的波動分析
  • 半固態製劑契約製造市場：按產品分類，估算和預測（2021-2033 年）
  • 奶油
  • 軟膏
  • 凝膠
  • 洗劑
  • 貼上
  • 其他

第6章：半固態製劑契約製造市場：依最終用途分類的估算與趨勢分析

  • 半固態製劑契約製造市場：依最終用途分類的波動分析
  • 半固態製劑契約製造市場：按最終用途分類的估算和預測（2021-2033 年）
  • 製藥公司
  • 藥用化妝品公司
  • 其他

第7章：半固態製劑契約製造市場：公司規模、預測與趨勢分析

  • 半固態製劑契約製造市場：依公司規模分類的波動分析
  • 半固態製劑契約製造市場：公司規模、估算與預測（2021-2033 年）
  • 大公司
  • 中型企業/中小企業
  • 其他

第8章：半固態製劑契約製造市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 主要公司分類
    • 主要市場參與企業
    • 參與企業新興市場
  • 2025年市場估值分析（熱圖分析）
  • 公司簡介
    • Lonza Group Ltd.
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceutical CDMO
    • Ascendia Pharmaceuticals
    • Pierre Fabre group
    • Piramal Pharma Solutions
    • DPT Laboratories, LTD
    • MedPharm Ltd
    • Catalent, Inc.
    • Recipharm AB
    • Aenova Group
    • Almac Group
    • Ajinomoto Bio-Pharma Services
Product Code: GVR-4-68040-345-3

Semi-solid Dosage Contract Manufacturing Market Summary

The global semi-solid dosage contract manufacturing market size was estimated at USD 21.21 billion in 2025, and is projected to reach USD 50.36 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The rising demand for dermatological drug formulations, shifting outsourcing trends, and the growing need for patient-friendly medications, coupled with the prevalence of chronic diseases such as skin diseases, arthritis, and pain management, are driving the market.

Besides, the growing demand for manufacturing outsourcing, due to cost-effectiveness, is expected to drive the market growth. Furthermore, regulatory compliance and quality assurance, as well as technological advancements, including innovation in formulation technologies, are expected to boost market growth over the forecast period. Besides, most pharmaceutical companies are focusing on their core functions, such as drug discovery and commercialization, which has led contract manufacturing organizations (CMOs) to become vital partners in the development, scale-up, and commercial production of semi-solid dosages.

Semi-solid dosage forms, such as creams, ointments, gels, and lotions, have gained increased attention as a key formulation segment due to their capacity for targeted, localized therapy and high patient compliance. These forms are particularly beneficial in dermatology and pain management, as direct application to the affected area allows for a faster onset of action, reduced systemic exposure, and improved safety profiles. In addition, commercially, their non-invasive nature and ease of use make them ideal for chronic treatment, further contributing to market growth.

Moreover, the increasing global burden of skin diseases is expected to drive the market growth, with over 1.8 billion individuals affected by more than 3,000 skin conditions, making dermatological disorders a top contributor to the global disease burden. In addition, the rising prevalence of arthritis affecting more than 350 million people worldwide and the expanding elderly population are further promoting the use of topical analgesics and anti-inflammatory formulations. These products are valued for reducing the gastrointestinal risks commonly associated with oral therapies.

In addition, technological advancements are expected to drive the market due to growing advancements in formulation science, such as nanoemulsions, liposomal delivery systems, and permeation-enhancing technologies, which are significantly enhancing drug efficacy, stability, and patient compliance. CMOs are making substantial investments in automated manufacturing systems, continuous processing, and advanced mixing and homogenization equipment to ensure consistent batch quality, regulatory adherence, and cost-effectiveness. Furthermore, the adoption of quality-by-design (QbD) frameworks and digital monitoring tools is improving process control and reducing time-to-market.

Global Semi-solid Dosage Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global semi-solid dosage contract manufacturing market report based on type, product, end use, company size, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Topical
  • Transdermal
  • Oral
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Creams
  • Ointments
  • Gels
  • Lotions
  • Pastes
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical Companies
  • Cosmeceutical Companies
  • Others
  • Company Size Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Size Companies
  • Medium & Small Size Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Company Size
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Semi-solid Dosage Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Demand for Patient-Friendly Medications
      • 3.2.1.2. Growing Prevalence of Chronic Diseases
      • 3.2.1.3. Growing Demand of Outsourcing Services
      • 3.2.1.4. Regulatory Compliance
      • 3.2.1.5. Technological Advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality control challenges
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Semi-solid Dosage Contract Manufacturing Market: Type Estimates & Trend Analysis

  • 4.1. Semi-solid Dosage Contract Manufacturing Market, By Type: Segment Dashboard
  • 4.2. Semi-solid Dosage Contract Manufacturing Market, By Type: Movement Analysis
  • 4.3. Semi-solid Dosage Contract Manufacturing Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 4.4. Topical
    • 4.4.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Transdermal
    • 4.5.1. Transdermal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Oral
    • 4.6.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Semi-solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Semi-solid Dosage Contract Manufacturing Market, By Product: Segment Dashboard
  • 5.2. Semi-solid Dosage Contract Manufacturing Market, By Product: Movement Analysis
  • 5.3. Semi-solid Dosage Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
  • 5.4. Creams
    • 5.4.1. Creams Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ointments
    • 5.5.1. Ointments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Gels
    • 5.6.1. Gels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Lotions
    • 5.7.1. Lotions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Pastes
    • 5.8.1. Pastes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Semi-solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Semi-solid Dosage Contract Manufacturing Market, By End Use: Segment Dashboard
  • 6.2. Semi-solid Dosage Contract Manufacturing Market, By End Use: Movement Analysis
  • 6.3. Semi-solid Dosage Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical Companies
    • 6.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Cosmeceutical Companies
    • 6.5.1. Cosmeceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Semi-solid Dosage Contract Manufacturing Market: Company Size Estimates & Trend Analysis

  • 7.1. Semi-solid Dosage Contract Manufacturing Market, By Company Size: Segment Dashboard
  • 7.2. Semi-solid Dosage Contract Manufacturing Market, By Company Size: Movement Analysis
  • 7.3. Semi-solid Dosage Contract Manufacturing Market Estimates & Forecasts, By Company Size, 2021 - 2033 (USD Million)
  • 7.4. Large Size Companies
    • 7.4.1. Large Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Medium & Small Size Companies
    • 7.5.1. Medium & Small Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Semi-solid Dosage Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Lonza Group Ltd.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Lubrizol Life Science
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Cambrex Corporation
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Contract Pharmaceuticals Limited
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Bora Pharmaceutical CDMO
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Ascendia Pharmaceuticals
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Pierre Fabre group
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Piramal Pharma Solutions
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. DPT Laboratories, LTD
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. MedPharm Ltd
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Catalent, Inc.
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Recipharm AB
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Aenova Group
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Almac Group
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Ajinomoto Bio-Pharma Services
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 Global Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 6 Global Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 7 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 9 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 11 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 12 U.S. Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 13 U.S. Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 16 Canada Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 17 Canada Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Canada Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 20 Mexico Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 21 Mexico Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Mexico Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 24 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 26 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 28 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 29 UK Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 30 UK Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 31 UK Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 32 UK Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 33 Germany Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 34 Germany Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 36 Germany Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 37 France Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 38 France Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 40 France Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 41 Italy Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 42 Italy Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Italy Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 45 Spain Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 46 Spain Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 48 Spain Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 49 Denmark Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 50 Denmark Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 52 Denmark Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 53 Sweden Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 54 Sweden Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 56 Sweden Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 57 Norway Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 58 Norway Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60 Norway Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 66 Japan Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 67 Japan Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Japan Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 70 China Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 71 China Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 72 China Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 73 China Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 74 India Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 75 India Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 77 India Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 78 Australia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 79 Australia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 81 Australia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 82 Thailand Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 83 Thailand Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 85 Thailand Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 86 South Korea Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 87 South Korea Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 89 South Korea Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 90 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 92 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 94 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 95 Brazil Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 96 Brazil Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98 Brazil Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 99 Argentina Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 100 Argentina Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 102 Argentina Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 108 South Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 109 South Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 111 South Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 116 UAE Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 117 UAE Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 119 UAE Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 124 Oman Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 125 Oman Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 126 Oman Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 127 Oman Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)
  • Table 128 Qatar Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 129 Qatar Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 130 Qatar Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 131 Qatar Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, by Company Size, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Semi-solid Dosage Contract Manufacturing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Semi-solid Dosage Contract Manufacturing Market: Type outlook and key takeaways
  • Fig. 20 Semi-solid Dosage Contract Manufacturing Market: Type movement analysis
  • Fig. 21 Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Transdermal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Semi-solid Dosage Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 25 Semi-solid Dosage Contract Manufacturing Market: Product movement analysis
  • Fig. 26 Creams Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Ointments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Gels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Lotions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Pastes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Semi-solid Dosage Contract Manufacturing Market: End use outlook and key takeaways
  • Fig. 33 Semi-solid Dosage Contract Manufacturing Market: End use movement analysis
  • Fig. 34 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Cosmeceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Semi-solid Dosage Contract Manufacturing Market: Company size outlook and key takeaways
  • Fig. 38 Semi-solid Dosage Contract Manufacturing Market: Company size movement analysis
  • Fig. 39 Large Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Medium & Small Size Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 North America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Mexico Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Germany Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 France Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Italy Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Spain Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Denmark Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Sweden Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Japan Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 China Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 India Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Australia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Thailand Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Korea Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Latin America Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Brazil Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Argentina Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 MEA Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 South Africa Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UAE Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Kuwait Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Qatar Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Oman Semi-solid Dosage Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key company categorization
  • Fig. 99 Service heat map analysis
  • Fig. 100 Strategic framework